StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.58+0.82 (+6.43%)

Close on Nov 17, 2026Market cap $476.21MP/E –Yield –

Fennec Pharmaceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Fennec Pharmaceuticals's enterprise value was $331.51M on Nov 11, 2026, against $207.88M a year earlier. Over the last 5 years it ranged from $76.10M to $391.42M, with a median of $201.23M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$331.51M+70.8%
2025Dec 31, 2025$194.13M+46.0%
2024Dec 31, 2024$132.99M-53.6%
2023Dec 29, 2023$286.45M+15.9%
2022Dec 30, 2022$247.13M+174.3%
2021Dec 31, 2021$90.10M-43.4%
2020Dec 31, 2020$159.12M+39.7%
2019Dec 31, 2019$113.89M+20.8%
2018Dec 31, 2018$94.27M-36.8%
2017Dec 29, 2017$149.20M–
2016Dec 30, 2016-$4.51M–

More Fennec Pharmaceuticals figures

See a number that looks wrong?